Skip to main content
. Author manuscript; available in PMC: 2012 Apr 24.
Published in final edited form as: J Neuropathol Exp Neurol. 2008 Aug;67(8):773–783. doi: 10.1097/NEN.0b013e318180ec47

Figure 4.

Figure 4

βAPP mRNA declines in AD initiation and progression. Total RNA was extracted from amygdala of brains diagnosed as control, AD (n = 5), or high-pathology controls (HPC; clinically nondemented but with AD pathology; n = 3). RNA was subjected to qRT-PCR and scaled relative to input RNA quantity in a standard curve. Final values were corrected by the signal for 18S rRNA. ***p < 0.00006 vs. control (Student t-test)